Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
Antibiotics (Basel, Switzerland)|June 25, 2025
Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational StudyKathrin Marx, Nina Malmström, Marie Quast, et al.Antimicrobial Agents and Chemotherapy|August 21, 2019
Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill PatientsTobias Lahmer, Gonzalo Batres Baires, Markus Heilmaier, et al.Antimicrobial Agents and Chemotherapy|April 28, 2005
Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteersWolfgang A Krueger, Jurgen Bulitta, Martina Kinzig-Schippers, et al.Antimicrobial Agents and Chemotherapy|November 7, 2012
The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum β-lactamases in experimental pneumonia in ratsWil H F Goessens, Johan W Mouton, Marian T Ten Kate, et al.Antimicrobial Agents and Chemotherapy|August 22, 2012
Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profileCornelia B Landersdorfer, Jurgen B Bulitta, Carl M J Kirkpatrick, et al.Chemotherapy|October 26, 2011
Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combinationJurgen B Bulitta, Martina Kinzig, Christoph K Naber, et al.Antimicrobial Agents and Chemotherapy|April 28, 2005
Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?Martina Kinzig-Schippers, Dorota Tomalik-Scharte, Alexander Jetter, et al.Diagnostic Microbiology and Infectious Disease|September 21, 2010
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulationLois S Lee, Martina Kinzig-Schippers, Anne N Nafziger, et al.Journal of Pharmaceutical and Biomedical Analysis|May 25, 2019
The contamination of valsartan and other sartans, part 1: New findingsFritz Sörgel, Martina Kinzig, Mona Abdel-Tawab, et al.European Journal of Clinical Pharmacology|January 30, 2004
Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposureAlexander Jetter, Martina Kinzig-Schippers, Michael Illauer, et al.Pageof 9